New (68)Ga-PhenA bisphosphonates as potential bone imaging agents.

Area of Science:

• Radiochemistry
• Nuclear Medicine
• Oncology

Background:

• Positron emission tomography (PET) bone imaging is crucial for cancer diagnosis and treatment monitoring.
• [(68)Ga]bisphosphonates offer potential for improved in vivo bone imaging.

Purpose of the Study:

• To develop novel [(68)Ga]bisphosphonates utilizing the AAZTA chelator.
• To evaluate the labeling efficiency and bone uptake of these new agents.

Main Methods:

• Synthesis of phenoxy derivatives of AAZTA (PhenA) with bisphosphonate groups.
• Labeling of the chelating agents with (68)Ga from a (68)Ge/(68)Ga generator.
• Biodistribution and autoradiography studies in normal mice.

Main Results:

• Rapid and efficient labeling (>95% in 5 min at room temperature) of [(68)Ga]PhenA-BPAMD and [(68)Ga]PhenA-HBP was achieved.
• The developed [(68)Ga]bisphosphonates exhibited excellent bone uptake in biodistribution and autoradiography studies.
• Improved labeling conditions eliminated the need for further purification.

Conclusions:

• Novel (68)Ga labeled bisphosphonates were successfully developed.
• These agents show potential as effective in vivo bone imaging agents for PET.
• Further investigation is warranted for clinical applications in cancer diagnosis and therapy monitoring.